We are live on ! Find out more
CMTA

Clementia Pharmaceuticals Inc.
CMTA

Delisted

CMTA was delisted on the 17th of April, 2019.

Back to rankings

48 hedge funds and large institutions have $732M invested in Clementia Pharmaceuticals Inc. in 2019 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more funds holding in top 10

Funds holding in top 10: 1 → 5 (+4)

155% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 11

108% more capital invested

Capital invested by funds: $352M → $732M (+$380M)

55% more funds holding

Funds holding: 31 → 48 (+17)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

Holders
48
Holders Change
+17
Holders Change %
+54.84%
% of All Funds
1.04%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.11%
New
28
Increased
7
Reduced
7
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KLCMU
Kite Lake Capital Management (UK)
United Kingdom
+$15.6M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$12.7M
3
Tudor Investment Corp
Tudor Investment Corp
Connecticut
+$7.7M
4
WIC
Water Island Capital
New York
+$7.17M
5
IA
IndexIQ Advisors
New York
+$5.23M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$35.3M
2
PA
Perceptive Advisors
New York
-$17.6M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$11.5M
4
DCM
Driehaus Capital Management
Illinois
-$11.2M
5
AG
Artal Group
Luxembourg
-$10M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$2.75M +$1.97M +105,407 New
AGM
27
Alpine Global Management
New York
$2.61M +$1.87M +100,000 New
PAMP
28
Polar Asset Management Partners
Ontario, Canada
$2.11M +$1.51M +81,000 New
AllianceBernstein
29
AllianceBernstein
Tennessee
$1.57M +$1.12M +60,000 New
GI
30
GAMCO Investors
Connecticut
$1.21M +$866K +46,356 New
Citigroup
31
Citigroup
New York
$1.13M +$810K +43,349 New
Geode Capital Management
32
Geode Capital Management
Massachusetts
$1.07M +$7.53K +403 +1%
CL
33
CSS LLC
Illinois
$1.06M +$756K +40,500 New
PCM
34
Prelude Capital Management
New York
$964K +$661K +35,397 +2,309%
USAA
35
United Services Automobile Association
Texas
$894K -$782K -41,855 -55%
BCA
36
Burren Capital Advisors
Gibraltar
$819K +$586K +31,381 New
OAC
37
OMERS Administration Corp
Ontario, Canada
$755K +$522K +27,932 New
Morgan Stanley
38
Morgan Stanley
New York
$639K -$298K -15,972 -39%
HM
39
Harvest Management
New York
$574K +$411K +22,000 New
Renaissance Technologies
40
Renaissance Technologies
New York
$305K +$219K +11,700 New
CS
41
Credit Suisse
Switzerland
$260K +$186K +9,977 New
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$252K +$180K +9,646 New
Deutsche Bank
43
Deutsche Bank
Germany
$242K +$174K +9,300 New
ECM
44
Element Capital Management
New York
$211K +$151K +8,076 New
UBS Group
45
UBS Group
Switzerland
$128K +$91.9K +4,918 New
MWNA
46
Marshall Wace North America
New York
$44K +$31.5K +1,685 New
TRCT
47
Tower Research Capital (TRC)
New York
$30K -$30.5K -1,632 -58%
FDCDDQ
48
Federation des caisses Desjardins du Quebec
Quebec, Canada
$13.1K – – –
PA
49
Perceptive Advisors
New York
– -$17.6M -1,500,000 Closed
AG
50
Artal Group
Luxembourg
– -$10M -850,000 Closed
1
2
3

CMTA Hedge Fund Activity: Q1 2019 in Review

48 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Clementia Pharmaceuticals Inc. (CMTA) for Q1 2019, worth a combined $732M — up 108% from $352M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new CMTA positions and 11 closed out — a net gain of 17 holders — while 7 added to existing stakes and 7 trimmed.

The largest buyer was Kite Lake Capital Management (UK), opening a new position worth an estimated $15.6M. The largest seller was Wellington Management Group, cutting an estimated $35.3M.

  • 48 institutional investors held Clementia Pharmaceuticals Inc. (CMTA) as of Q1 2019, up from 31 in Q4 2018.
  • Funds reported $732M of Clementia Pharmaceuticals Inc. stock for Q1 2019, up 108% quarter-over-quarter.
  • 28 funds opened new Clementia Pharmaceuticals Inc. positions in Q1 2019 and 11 closed out, a net change of +17 holders.
  • The largest Clementia Pharmaceuticals Inc. buyer in Q1 2019 was Kite Lake Capital Management (UK), an estimated $15.6M added.
  • The largest Clementia Pharmaceuticals Inc. seller in Q1 2019 was Wellington Management Group, an estimated $35.3M sold.

Based on aggregated 13F filings for Q1 2019.